-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Lexaria Bioscience Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2013 to Q2 2024.
- Lexaria Bioscience Corp. Operating Income (Loss) for the quarter ending May 31, 2024 was -$1.74M, a 27.4% increase year-over-year.
- Lexaria Bioscience Corp. Operating Income (Loss) for the twelve months ending May 31, 2024 was -$4.66M.
- Lexaria Bioscience Corp. annual Operating Income (Loss) for 2023 was -$6.53M, a 1.28% increase from 2022.
- Lexaria Bioscience Corp. annual Operating Income (Loss) for 2022 was -$6.62M, a 16.4% decline from 2021.
- Lexaria Bioscience Corp. annual Operating Income (Loss) for 2021 was -$5.69M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)